Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Gene Ther. 2010 Apr 29;17(8):939–948. doi: 10.1038/gt.2010.47

Figure 1.

Figure 1

The competitive repopulation assay using fluorescent reporter genes in the dog model. a) The ex vivo transduction is divided into two experimental arms with equivalent numbers of CD34+ cells. A vector expressing enhanced green fluorescent protein (EGFP) is used for one experimental arm, and a different vector different expressing enhanced yellow fluorescent protein (EYFP) is used for the other experimental arm. The two experimental arms can differ in a number of ways including vector type, vector envelope pseudotype, ex vivo transduction protocol, source of CD34+ cells, or route of infusion. By directly comparing one of these variables in the same dog, inter-animal variability is eliminated, and the best approach can be determined with a small number of animals. b) The use of EG/YFP fluorescent reporter genes allows easy and accurate evaluation of transgene expression by flow cytometry. c) Transgene expression can be evaluated long-term in both myeloid and lymphoid lineages.